T1	Participants 63 91	Patients With Heart Failure.
T2	Participants 143 234	patients with end-stage heart failure and ongoing symptoms despite optimal medical therapy.
T3	Participants 300 386	patients with either ischemic heart failure (IHF) or nonischemic heart failure (NIHF).
T4	Participants 569 615	Sixty patients were stratified by IHF and NIHF
T5	Participants 934 990	All 60 patients were successfully enrolled in the study.
T6	Participants 1902 1930	patients with heart failure.
